Two phase I studies of prime-boost vaccinations with vaccinia-fowlpox vaccines expressing CEA, MUC-1, and TRICOM costimulatory molecules (B7.1/ICAM-1/LFA-3) in patients with advanced pancreatic cancer
Thomas Schuetz(Dana-Farber Cancer Institute), Dennis Panicali(Fox Chase Cancer Center), John Marshall(Columbia University), Howard Safran(Brown University), Howard L. Kaufman(Rutgers, The State University of New Jersey)
Cited by 10
Related Papers
Oncolytic viruses: a new class of immunotherapy drugs
|Nature Reviews Drug Discovery|2015|1.6k
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
|Cell|1991|1.6k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|975
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
|JAMA Oncology|2015|656